May 22, 2026 03:59PM
May 7, 2026 07:00AM
Feb 26, 2026 07:00AM
Nov 6, 2025 07:02AM
Nov 6, 2025 07:00AM
Sep 24, 2025 04:51AM
Sep 24, 2025 01:00AM Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
Aug 6, 2025 07:00AM
Jul 22, 2025 09:13AM
Jul 22, 2025 08:55AM
Jul 22, 2025 07:00AM
Jul 22, 2025 07:00AM
May 7, 2025 07:00AM
May 6, 2025 04:01PM Lantheus Holdings (LNTH) Announces Sale of SPECT Business to SHINE Technologies
May 6, 2025 04:01PM
Apr 1, 2025 09:01AM
Apr 1, 2025 09:00AM
Feb 26, 2025 07:00AM
Feb 15, 2025 10:00PM
Jan 28, 2025 06:15AM
Jan 28, 2025 06:00AM Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
Jan 21, 2025 06:00PM
Jan 13, 2025 12:08AM
Jan 13, 2025 12:05AM
Nov 6, 2024 07:00AM
Sep 5, 2024 08:33AM
Sep 5, 2024 08:30AM
Jul 31, 2024 07:00AM Lantheus Reports Second Quarter 2024 Financial Results
Jul 15, 2024 08:31AM
Jul 15, 2024 08:30AM
Jun 27, 2024 07:05AM
Jun 27, 2024 07:05AM
May 2, 2024 07:00AM
Mar 5, 2024 08:06AM
Mar 5, 2024 08:00AM Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility
Feb 22, 2024 07:00AM
Jan 23, 2024 07:45AM
Jan 23, 2024 07:45AM
Jan 9, 2024 08:07AM
Jan 9, 2024 08:02AM
Jan 9, 2024 08:00AM
Jan 9, 2024 08:00AM Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability
Jan 9, 2024 07:55AM
Jan 9, 2024 07:55AM
Dec 18, 2023 07:33AM
Dec 18, 2023 07:30AM
Nov 2, 2023 07:00AM
Aug 3, 2023 07:00AM
May 23, 2023 08:30AM Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
May 4, 2023 07:00AM

1,154,856 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All